coli. Carbapenems are important therapeutic agents for the treatment of infections of extended-spectrum β-lactamase (ESBL)-producing isolates.7 Bacteria that possess the New Delhi metallo-β-lactamase (NDM) enzyme, the main carbapenemase detected in children,8 are resistant to ...
Naeem Ullah 1, Thadchaporn Assawakongkarat 2,Yukihiro Akeda 3 & Nuntaree Chaichanawongsaroj 1* Extraintestinal pathogenic Escherichia coli (ExPEC) producing extended-spectrum β-lactamases (ESBL) cause serious human infections due to their virulence and multidrug resistance (MDR...
ST410 (adk-fumC-gyrB-icd-mdh-purA-recA, 6-4-12-1-20-18-7) and ST206 (6-7-5-1-8-18-2) shared only three out of the seven alleles for MLST. ST410 E. coli has a worldwide distribution22,23,24 and a blaOXA-181-carrying ST410 E. coli, strain WCHEC14828, has been ...
Distribution of MDRE. coliisolates based on isolation sources. The bars represent the number of MDRE. coliisolates from humans working on the poultry farm or selling chickens at the live bird market (LBM); the number of MDRE. coliisolates from chickens at the poultry farm or LBM and the ...
The carbapenemase and ESBL genes, the host species, the locations of recovery and the GenBank accession number of each plasmid are shown. For host species, CF refers to Citrobacter freundii, EC to E. coli, ECL to E. cloacae, KP to K. pneumoniae and RP to Raoultella planticola. The ...
Quinolone resistance mechanisms among extended- spectrum beta-lactamase (ESBL) producing Escherichia coli isolated from rivers and lakes in Switzerland. PLoS One 9, e95864 (2014). 50. Barton, B. M., Harding, G. P. & Zuccarelli, A. J. A general method for detecting and sizing large ...
Escherichia colirepresents one of the most common causes of community-onset and nosocomial infections. Strains carrying extended spectrum β-lactamases (ESBL) are a serious public health problem. In Central America we have not found studies reporting the molecular epidemiology ofE. colistrains implicated...
The accelerated dispersion of multidrug-resistant (MDR) Escherichia coli due to the production of extended-spectrum β-lactamases (ESBLs) or AmpC enzymes has been noted in Egypt, presenting a serious treatment challenge. In this study, we investigate the prevalence of ESBLs and AmpC enzymes amon...
Background: Extended-spectrum β-lactamases (ESBL) in Escherichia coli are a serious concern due to their role in developing multidrug resistance (MDR) and difficult-to-treat infections. Objective: This study aimed to identify ESBL-carrying E. coli strains from both clinical and environmental source...
coli strains in Shandong Province, China [33], while Song et al. noted that the detection frequencies of the aphA3 resistance genes in chicken-derived E. coli strains were above 50% [34]. The CTX-M and TEM family of extended-spectrum beta-lactamases (ESBLs) has long been considered ...